Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2009, Article ID 146872, 8 pages
http://dx.doi.org/10.1155/2009/146872
Research Article

Increased Responsiveness of Human Coronary Artery Endothelial Cells in Inflammation and Coagulation

Department of Rheumatology, University Medical Centre, Vodnikova 62, 1000 Ljubljana, Slovenia

Received 16 July 2009; Accepted 26 October 2009

Academic Editor: Hidde Bult

Copyright © 2009 Katja Lakota et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Woods, D. J. Brull, S. E. Humphries, and H. E. Montgomery, “Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6,” European Heart Journal, vol. 21, no. 19, pp. 1574–1583, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Ross, “Atherosclerosis—an inflammatory disease,” New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. G. K. Hansson, “Inflammation, atherosclerosis, and coronary artery disease,” New England Journal of Medicine, vol. 352, no. 16, pp. 1685–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Lakota, K. Mrak-Poljsak, B. Rozman, T. Kveder, M. Tomsic, and S. Sodin-Semrl, “Serum amyloid A activation of inflammatory and adhesion molecules in human coronary artery and umbilical vein endothelial cells,” European Journal of Inflammation, vol. 5, no. 2, pp. 73–81, 2007. View at Google Scholar · View at Scopus
  5. D. B. Cines, E. S. Pollak, C. A. Buck et al., “Endothelial cells in physiology and in the pathophysiology of vascular disorders,” Blood, vol. 91, no. 10, pp. 3527–3561, 1998. View at Google Scholar · View at Scopus
  6. J. F. Stoltz, S. Muller, A. Kadi, V. Decot, P. Menu, and D. Bensoussan, “Introduction to endothelial cell biology,” Clinical Hemorheology and Microcirculation, vol. 37, no. 1-2, pp. 5–8, 2007. View at Google Scholar · View at Scopus
  7. K. Hatakeyama, Y. Asada, K. Marutsuka, Y. Sato, Y. Kamikubo, and A. Sumiyoshi, “Localization and activity of tissue factor in human aortic atherosclerotic lesions,” Atherosclerosis, vol. 133, no. 2, pp. 213–219, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. J. D. Marmur, M. Rossikhina, A. Guha et al., “Tissue factor is rapidly induced in arterial smooth muscle after balloon injury,” Journal of Clinical Investigation, vol. 91, no. 5, pp. 2253–2259, 1993. View at Google Scholar · View at Scopus
  9. R. M. McDouall, M. W. Farrar, S. Khan, M. H. Yacoub, and S. P. Allen, “Unique sensitivities to cytokine regulated expression of adhesion molecules in human heart-derived endothelial cells,” Endothelium, vol. 8, no. 1, pp. 25–40, 2001. View at Google Scholar · View at Scopus
  10. S. J. Duffy, J. F. Keaney Jr., M. Holbrook et al., “Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease,” Circulation, vol. 104, no. 2, pp. 151–156, 2001. View at Google Scholar · View at Scopus
  11. V. Stangl, M. Lorenz, and K. Stangl, “The role of tea and tea flavonoids in cardiovascular health,” Molecular Nutrition and Food Research, vol. 50, no. 2, pp. 218–228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Alexopoulos, C. Vlachopoulos, K. Aznaouridis et al., “The acute effect of green tea consumption on endothelial function in healthy individuals,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 15, no. 3, pp. 300–305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Ardalan, M. K. Tarzamni, M. M. Shoja et al., “Black tea improves endothelial function in renal transplant recipients,” Transplantation Proceedings, vol. 39, no. 4, pp. 1139–1142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Yokozawa, E. Dong, T. Nakagawa, D. W. Kim, M. Hattori, and H. Nakagawa, “Effects of Japanese black tea on atherosclerotic disorders,” Bioscience, Biotechnology and Biochemistry, vol. 62, no. 1, pp. 44–48, 1998. View at Google Scholar · View at Scopus
  15. A. K. Nag Chaudhuri, S. Karmakar, D. Roy, S. Pal, M. Pal, and T. Sen, “Anti-inflammatory activity of Indian black tea (Sikkim variety),” Pharmacological Research, vol. 51, no. 2, pp. 169–175, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Lorenz, J. Urban, U. Engelhardt, G. Baumann, K. Stangl, and V. Stangl, “Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved,” Basic Research in Cardiology, vol. 104, no. 1, pp. 100–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Lü, P. Hua, J. Yu, X. Jiang, and H. Leng, “Study on the effect of theaflavins on the adhesion between monocyte and endothelial cells,” Zhong Yao Cai, vol. 28, no. 4, pp. 304–306, 2005. View at Google Scholar · View at Scopus
  18. H. Yoshida, T. Ishikawa, H. Hosoai et al., “Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein,” Biochemical Pharmacology, vol. 58, no. 11, pp. 1695–1703, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Das, D. D. Santani, and N. S. Dhalla, “Experimental evidence for the cardioprotective effects of red wine,” Experimental and Clinical Cardiology, vol. 12, no. 1, pp. 5–10, 2007. View at Google Scholar · View at Scopus
  20. E. Wenzel and V. Somoza, “Metabolism and bioavailability of trans-resveratrol,” Molecular Nutrition and Food Research, vol. 49, no. 5, pp. 472–481, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. U. R. Pendurthi, J. T. Williams, and L. V. M. Rao, “Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: a possible mechanism for the cardiovascular benefits associated with moderate consumption of wine,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 2, pp. 419–426, 1999. View at Google Scholar · View at Scopus
  22. S. K. Manna, A. Mukhopadhyay, and B. B. Aggarwal, “Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation,” Journal of Immunology, vol. 164, no. 12, pp. 6509–6519, 2000. View at Google Scholar · View at Scopus
  23. Y. Takada, A. Bhardwaj, P. Potdar, and B. B. Aggarwal, “Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation,” Oncogene, vol. 23, no. 57, pp. 9247–9258, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Csiszar, K. Smith, N. Labinskyy, Z. Orosz, A. Rivera, and Z. Ungvari, “Resveratrol attenuates TNF-α-induced activation of coronary arterial endothelial cells: role of NF-κB inhibition,” American Journal of Physiology, vol. 291, no. 4, pp. H1694–H1699, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Briones, D. J. Phillips, M. A. Renshaw, and W. C. Hooper, “Expression of chemokine by human coronary-artery and umbilical-vein endothelial cells and its regulation by inflammatory cytokines,” Coronary Artery Disease, vol. 12, no. 3, pp. 179–186, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. W. C. Hooper, D. J. Phillips, M. A. Renshaw, B. L. Evatt, and J. M. Benson, “The up-regulation of IL-6 and IL-8 in human endothelial cells by activated protein C,” Journal of Immunology, vol. 161, no. 5, pp. 2567–2573, 1998. View at Google Scholar · View at Scopus
  27. N. Franscini, E. B. Bachli, N. Blau, M.-S. Leikauf, A. Schaffner, and G. Schoedon, “Gene expression profiling of inflamed human endothelial cells and influence of activated protein C,” Circulation, vol. 110, no. 18, pp. 2903–2909, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Zeuke, A. J. Ulmer, S. Kusumoto, H. A. Katus, and H. Heine, “TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS,” Cardiovascular Research, vol. 56, no. 1, pp. 126–134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Vlachopoulos, N. Alexopoulos, I. Dima, K. Aznaouridis, I. Andreadou, and C. Stefanadis, “Acute effect of black and green tea on aortic stiffness and wave reflections,” Journal of the American College of Nutrition, vol. 25, no. 3, pp. 216–223, 2006. View at Google Scholar · View at Scopus
  30. J. A. M. Kyle, P. C. Morrice, G. McNeill, and G. G. Duthie, “Effects of infusion time and addition of milk on content and absorption of polyphenols from black tea,” Journal of Agricultural and Food Chemistry, vol. 55, no. 12, pp. 4889–4894, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Hasalam, Plant Phenols: Vegetable Tannins Revisited, Cambrige University Press, Cambridge, UK, 1989.
  32. C. S. Yang, J. Y. Chung, G.-Y. Yang, S. K. Chhabra, and M.-J. Lee, “Tea and tea polyphenols in cancer prevention,” Journal of Nutrition, vol. 130, no. 2, supplement, pp. 472S–478S, 2000. View at Google Scholar · View at Scopus
  33. J. A. Vita, “Polyphenols and cardiovascular disease: effects on endothelial and platelet function,” The American Journal of Clinical Nutrition, vol. 81, no. 1, supplement, pp. 292S–297S, 2005. View at Google Scholar · View at Scopus
  34. U. Peters, C. Poole, and L. Arab, “Does tea affect cardiovascular disease? A meta-analysis,” American Journal of Epidemiology, vol. 154, no. 6, pp. 495–503, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Arab, W. Liu, and D. Elashoff, “Green and black tea consumption and risk of stroke: a meta-analysis,” Stroke, vol. 40, no. 5, pp. 1786–1792, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Debette, D. Courbon, N. Leone et al., “Tea consumption is inversely associated with carotid plaques in women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 353–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. R. A. Riemersma, C. A. Rice-Evans, R. M. Tyrrell, M. N. Clifford, and M. E. J. Lean, “Tea flavonoids and cardiovascular health,” QJM, vol. 94, no. 5, pp. 277–282, 2001. View at Google Scholar · View at Scopus
  38. H. Dreger, M. Lorenz, A. Kehrer, G. Baumann, K. Stangl, and V. Stangl, “Characteristics of catechin- and theaflavin-mediated cardioprotection,” Experimental Biology and Medicine, vol. 233, no. 4, pp. 427–433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Anter, K. Chen, O. M. Shapira, R. H. Karas, and J. F. Keaney Jr., “p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor α-dependent pathway in response to black tea polyphenols,” Circulation Research, vol. 96, no. 10, pp. 1072–1078, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Lorenz, J. Urban, U. Engelhardt, G. Baumann, K. Stangl, and V. Stangl, “Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved,” Basic Research in Cardiology, vol. 104, no. 1, pp. 100–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Agewall, S. Wright, R. N. Doughty, G. A. Whalley, M. Duxbury, and N. Sharpe, “Does a glass of red wine improve endothelial function?” European Heart Journal, vol. 21, no. 1, pp. 74–78, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. L. H. Opie and S. Lecour, “The red wine hypothesis: from concepts to protective signalling molecules,” European Heart Journal, vol. 28, no. 14, pp. 1683–1693, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Szende, E. Tyihák, and Z. Király-Véghely, “Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures,” Experimental and Molecular Medicine, vol. 32, no. 2, pp. 88–92, 2000. View at Google Scholar · View at Scopus
  44. P. Vitaglione, S. Sforza, G. Galaverna et al., “Bioavailability of trans-resveratrol from red wine in humans,” Molecular Nutrition and Food Research, vol. 49, no. 5, pp. 495–504, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Saiko, A. Szakmary, W. Jaeger, and T. Szekeres, “Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?” Mutation Research, vol. 658, no. 1-2, pp. 68–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. A. A. E. Bertelli, L. Giovannini, R. Stradi, A. Bertelli, and J.-P. Tillement, “Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats,” International Journal of Tissue Reactions, vol. 18, no. 2-3, pp. 67–71, 1996. View at Google Scholar · View at Scopus
  47. F. Pellegatta, A. A. E. Bertelli, B. Staels, C. Duhem, A. Fulgenzi, and M. E. Ferrero, “Different short- and long-term effects of resveratrol on nuclear factor-κB phosphorylation and nuclear appearance in human endothelial cells,” American Journal of Clinical Nutrition, vol. 77, no. 5, pp. 1220–1228, 2003. View at Google Scholar · View at Scopus
  48. D. K. Das and N. Maulik, “Resveratrol in cardioprotection: a therapeutic promise of alternative medicine,” Molecular Interventions, vol. 6, no. 1, pp. 36–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. M. E. Ferrero, A. A. E. Bertelli, A. Fulgenzi et al., “Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium,” American Journal of Clinical Nutrition, vol. 68, no. 6, pp. 1208–1214, 1998. View at Google Scholar · View at Scopus
  50. B. Olas, B. Wachowicz, J. Saluk-Juszczak, and T. Zieliński, “Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin,” Thrombosis Research, vol. 107, no. 3-4, pp. 141–145, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. H.-J. Park, S.-K. Jeong, S.-R. Kim et al., “Resveratrol inhibits Porphyromonas gingivalis lipopolysaccharide-induced endothelial adhesion molecule expression by suppressing NF-?B activation,” Archives of Pharmacal Research, vol. 32, no. 4, pp. 583–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. C.-C. Wu, C.-I. Wu, W.-Y. Wang, and Y.-C. Wu, “Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins,” Planta Medica, vol. 73, no. 5, pp. 439–443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. A. M. El-Mowafy and R. E. White, “Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects,” FEBS Letters, vol. 451, no. 1, pp. 63–67, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. O.-H. Kang, H.-J. Jang, H.-S. Chae et al., “Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-?B and MAPK,” Pharmacological Research, vol. 59, no. 5, pp. 330–337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. B. S. Wung, M. C. Hsu, C. C. Wu, and C. W. Hsieh, “Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation,” Life Sciences, vol. 78, no. 4, pp. 389–397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. S. J. Slater, J. L. Seiz, A. C. Cook, B. A. Stagliano, and C. J. Buzas, “Inhibition of protein kinase C by resveratrol,” Biochimica et Biophysica Acta, vol. 1637, no. 1, pp. 59–69, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Olszanecki, A. Gebska, and R. Korbut, “Production of prostacyclin and prostaglandin E2 in resting and IL-1β-stimulated A549, HUVEC and hybrid EA.hy 926 cells,” Journal of Physiology and Pharmacology, vol. 57, no. 4, pp. 649–660, 2006. View at Google Scholar · View at Scopus
  58. S. K. Nicholson, G. A. Tucker, and J. M. Brameld, “Effects of dietary polyphenols on gene expression in human vascular endothelial cells,” Proceedings of the Nutrition Society, vol. 67, no. 1, pp. 42–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Orallo, E. Alvarez, M. Camiña, J. M. Leiro, E. Gómez, and P. Fernandez, “The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption,” Molecular Pharmacology, vol. 61, no. 2, pp. 294–302, 2002. View at Publisher · View at Google Scholar · View at Scopus